Abeona Therapeutics Inc. Income Statement

Income Statement Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & Cost
Revenue 1.84M4.40M2.04M0.93M1.04M0.89M0.84M3.00M10.00M3.00M1.41M3.50M0.04M
Interest income
Interest Income - Total 0.04M0.43M2.12M4.25M
Interest expenses
Interest Expense - Others 0.01M0.01M0.40M0.60M0.07M
Interest Expenses 0.96M0.61M0.28M0.58M0.01M0.01M0.01M0.01M4.12M3.66M0.74M0.42M4.21M
Interest Income - Net -3.62M-0.30M1.70M0.04M
Operating Items
Research & Development 3.58M2.01M0.88M0.33M4.71M10.65M16.99M38.70M30.14M38.73M28.96M31.09M34.36M
Selling, General & Administrative 5.75M6.02M4.83M3.71M14.32M13.29M10.94M20.11M23.78M21.64M17.26M19.00M29.85M
Other Operating Expenses 0.38M0.69M0.13M0.01M0.55M0.82M0.74M2.36M37.50M32.47M6.11M0.54M
Operating Expenses 9.71M8.72M5.85M4.06M19.59M24.77M28.67M61.16M91.42M92.84M52.33M50.63M64.21M
Operating Income -7.88M-4.32M-3.80M-3.13M-18.55M-23.88M-27.84M-58.17M-81.42M-89.84M-50.91M-47.13M-64.21M
EBIT -7.88M-4.32M-3.80M-3.13M-18.55M-23.88M-27.84M-58.17M-81.42M-89.84M-50.91M-47.13M-64.21M
Non-operating items
Interest & Investment Income 1.33M0.24M0.25M0.04M4.03M2.01M0.53M1.51M1.30M0.07M
Other Non Operating Income 3.58M-4.77M8.01M-23.11M
Non Operating Income 5.36M-6.22M8.25M-23.65M4.02M2.01M0.52M0.14M2.94M1.19M
Net income details
EBT -2.52M-10.53M-3.83M-3.67M-14.53M-21.87M-27.32M-56.67M-84.23M-93.42M-51.65M-47.55M-68.42M
Tax Provisions 0.02M
Profit After Tax -2.53M-10.53M4.45M-26.78M-14.53M-21.87M-27.32M-56.67M-84.23M-84.94M-39.70M-54.19M-63.73M
Income from Continuing Operations -2.53M-10.53M-3.83M-3.67M-14.53M-21.87M-27.32M-56.67M-84.23M-93.42M-51.65M-47.55M-68.42M
Consolidated Net Income -2.53M-10.53M-3.83M-3.67M-14.53M-21.87M-27.32M-56.67M-84.23M-93.42M-51.65M-47.55M-68.42M
Income towards Parent Company -2.53M-10.53M-3.83M-3.67M-14.53M-21.87M-27.32M-56.67M-84.23M-93.42M-51.65M-47.55M-68.42M
Preferred Dividend Payments 1.77M2.00M2.90M2.88M3.78M
Net Income towards Common Stockholders -4.31M-12.53M1.55M-29.65M-14.53M-21.87M-27.32M-56.67M-84.23M-84.94M-43.50M-54.20M-63.70M
Additional items
EPS (Basic) -0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.02M0.02M0.02M0.02M1.31M1.60M1.87M1.92M2.05M3.94M4.08M17.18M24.77M43.47M
Shares Outstanding (Diluted Average) 7.86M21.38M41.05M
EBITDA -7.88M-4.32M-3.80M-3.13M-18.55M-23.88M-27.84M-58.17M-84.24M-84.95M-43.58M-54.12M-63.66M